Listar Technical documents and research evidence on COVID-19 por título
Mostrando ítems 1-20 de 1749
-
The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological respopersons with and without pre-existing heterologous group B immunity
(2014)Serological studies of persons infected with yellow fever (YF) during the 1970 epidemic in Okwoga District, Nigeria, indicated that epidemic YF occurred despite a high prevalence of pre-existing group B arbovirus immunity, ... -
2019-ncov's epidemic in middle province of northern Italy: impact, logistic & strategy in the first line hospital
(2020-03-24)The novel coronavirus (2019-nCoV) began in China in early December 2019 and rapidly has spread to many countries around the globe, with the number of confirmed cases increasing every day. An epidemic has been recorded since ... -
The 2019-new Coronavirus Epidemic: Evidence for Virus Evolution
There is a worldwide concern about the new coronavirus 2019-nCoV as a global public health threat. In this article, we provide a preliminary evolutionary and molecular epidemiological analysis of this new virus. A phylogenetic ... -
The 3.8 Å resolution cryo-EM structure of Zika virus
(2016-06)The recent rapid spread of Zika virus and its unexpected linkage to birth defects and an autoimmune neurological syndrome have generated worldwide concern. Zika virus is a flavivirus like the dengue, yellow fever, and West ... -
30 Critical Concepts for Fighting COVID-19 in the Age of Digital Interdependence
(2020-09-11)As millions of people around the world are quarantined or in physical isolation, with border closings and restrictions in travel, Information Technologies (IT) have become the main means of interaction and communication. ... -
Acceptability of app-based contact tracing for COVID-19: Cross-country survey evidence
(2020-05-08)Background: The COVID-19 pandemic is the greatest public health crisis of the last 100 years. Countries have responded with various levels of lockdown to save lives and stop health systems from being overwhelmed. At the ... -
Access the guidance COVID-19 Partners Platform based on Operational Planning Guidance Training modules: Operational Planning Guidelines and COVID-19 Partners Platform
On 30 January 2020, the Director-General of WHO declared the coronavirus disease 2019 (COVID-19) outbreak a public health emergency of international concern (PHEIC) under the International Health Regulations (IHR 2005), ... -
Access to Essential Medicines for Noncommunicable Diseases during the COVID-19 Pandemic
(2020-07-13)Appropriate and adequate management of people with noncommunicable diseases (NCDs) includes access to essential NCD medicines. Disrupted access to chronic medication for hypertension, diabetes, heart disease, mental health ... -
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
(2020-05-01)Aims: The question of interactions between the renin angiotensin aldosterone system drugs and the incidence and prognosis of COVID-19 infection has been raised by the medical community. We hypothesised that if patients ... -
Acute Kidney Injury in Hospitalized Patients with COVID-19
(2020-05-08)Importance: Preliminary reports indicate that acute kidney injury (AKI) is common in coronavirus disease (COVID)-19 patients and is associated with worse outcomes. AKI in hospitalized COVID-19 patients in the United States ... -
Acute myelitis due to Zika virus infection
(2016-06)In January, 2016, a 15-year-old girl with a history only of an ovarian cyst was admitted to hospital in Pointe-à-Pitre, Guadeloupe, with left hemiparesis. 7 days previously she had presented to the emergency department ... -
Acute Physiology and Chronic Health Evaluation II Score as a Predictor of Hospital Mortality in Patients of Coronavirus Disease 2019
(2020-05-01)Objectives: Coronavirus disease 2019 has emerged as a major global health threat with a great number of deaths in China. We aimed to assess the association between Acute Physiology and Chronic Health Evaluation II score ... -
Acute Zika infection with concurrent onset of Guillain-Barré Syndrome
(2016-07)A 47-year-old Tongan male returning to New Zealand after a 2-week holiday in Tonga presented with 3 days of progressive limb weakness, numbness, unsteady gait, and dyspnea. Two days before departing Tonga (6 days before ... -
Acute Zika Virus Infection after Travel to Malaysian Borneo, September 2014
(2016)Zika virus (ZIKV), a mosquito-borne flavivirus, causes Zika fever, a self-limiting febrile and exanthematic arthralgia syndrome closely resembling dengue fever. Most often, signs and symptoms are maculopapular rash, fever, ... -
Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples
(2020-04-22)Background: A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China in late 2019 and subsequently caused a pandemic. Surveillance is important to better appreciate this evolving ... -
The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis
(2020-07)Background: Chinese herbal medicine (CHM) is thought to be a potential intervention in the treatment of coronavirus disease (COVID-19). Purpose: This study aimed to investigate the efficacy and safety of CHM or CHM ... -
Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
(2020-10-02)Introduction: Tocilizumab (TCZ) is an anti-interleukin-6 antibody that has been used for the treatment of severe coronavirus disease 2019 (COVID-19). However, concrete evidence of its benefit in reducing mortality in severe ... -
Additional steroid treatment for patients with influenza who are critically ill: Uncertain whether beneficial or harmful
(2020-03-16)What is this? Corticosteroids are widely used for people with severe influenza, but there is uncertainty about their potential benefits or harms. Corticosteroids have shown evidence of benefit in sepsis and related conditions, ...